Hugen PW - Search Results

1

No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients.

Schippers EF, Hugen PW, den Hartigh J, Burger DM, Hoetelmans RM, Visser LG, Kroon FP. Schippers EF, et al. Among authors: hugen pw. AIDS. 2000 Dec 1;14(17):2794-5. doi: 10.1097/00002030-200012010-00023. AIDS. 2000. PMID: 11125902 No abstract available.

2

Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals.

Burger D, Hugen P, Reiss P, Gyssens I, Schneider M, Kroon F, Schreij G, Brinkman K, Richter C, Prins J, Aarnoutse R, Lange J; ATHENA Cohort Study Group. Burger D, et al. AIDS. 2003 May 23;17(8):1157-65. doi: 10.1097/00002030-200305230-00007. AIDS. 2003. PMID: 12819517 Clinical Trial.

3

Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients.

Brinkman K, Kroon F, Hugen PW, Burger DM. Brinkman K, et al. Among authors: hugen pw. AIDS. 1998 Mar 26;12(5):537. AIDS. 1998. PMID: 9543457 No abstract available.

4

Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir.

Burger DM, Hugen PW, Kroon FP, Groeneveld P, Brinkman K, Foudraine NA, Sprenger H, Koopmans PP, Hekster YA. Burger DM, et al. Among authors: hugen pw. AIDS. 1998 Oct 22;12(15):2080-2. doi: 10.1097/00002030-199815000-00025. AIDS. 1998. PMID: 9814882 No abstract available.

5

Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.

Burger DM, Hugen PW, van der Ende ME, van Wijngaarden P, Aarnoutse RE, Reiss P, Lange JM. Burger DM, et al. Among authors: hugen pw. AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032. AIDS. 2000. PMID: 11101081 Clinical Trial. No abstract available.

6

Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.

Baede-van Dijk PA, Hugen PW, Verweij-van Wissen CP, Koopmans PP, Burger DM, Hekster YA. Baede-van Dijk PA, et al. Among authors: hugen pw. AIDS. 2001 May 25;15(8):991-8. doi: 10.1097/00002030-200105250-00007. AIDS. 2001. PMID: 11399981 Clinical Trial.

7

Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children.

van Rossum AM, Bergshoeff AS, Fraaij PL, Hugen PW, Hartwig NG, Geelen SP, Wolfs TF, Weemaes CM, De Groot R, Burger DM. van Rossum AM, et al. Among authors: hugen pw. Pediatr Infect Dis J. 2002 Aug;21(8):743-7. doi: 10.1097/00006454-200208000-00009. Pediatr Infect Dis J. 2002. PMID: 12192162 Clinical Trial.

8

Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.

Hugen PW, Verweij-van Wissen CP, Burger DM, Wuis EW, Koopmans PP, Hekster YA. Hugen PW, et al. J Chromatogr B Biomed Sci Appl. 1999 Apr 30;727(1-2):139-49. doi: 10.1016/s0378-4347(99)00079-1. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10360433

9

Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy.

Burger DM, Hoetelmans RM, Hugen PW, Mulder JW, Meenhorst PL, Koopmans PP, Brinkman K, Keuter M, Dolmans W, Hekster YA. Burger DM, et al. Among authors: hugen pw. Antivir Ther. 1998;3(4):215-20. Antivir Ther. 1998. PMID: 10682141

10

Carbamazepine--indinavir interaction causes antiretroviral therapy failure.

Hugen PW, Burger DM, Brinkman K, ter Hofstede HJ, Schuurman R, Koopmans PP, Hekster YA. Hugen PW, et al. Ann Pharmacother. 2000 Apr;34(4):465-70. doi: 10.1345/aph.19211. Ann Pharmacother. 2000. PMID: 10772431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters